Skip to main content

Table 2 Spearman’s rho correlation coefficient and P value between Miller-Payne grade and tumor pathological variables (MC, NS), tumor subtype (HER2, ER, TN), tHb, and %tHb measured at the end of cycles 1 to 3

From: Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters

 

NS

MC

HER2

ER

TN

tHb

%tHb cycle 1

%tHb cycle 2

%tHb cycle 3

rho

0.42

0.45

0.45

0.29

0.12

0.48

0.50

0.52

0.69

P

P = 0.001

P < 0.001

P < 0.001

P = 0.035

P = 0.364

P < 0.001

P < 0.001

P < 0.001

P < 0.001

  1. Data are from [20] and this study (n = 54 patients)
  2. ER estrogen receptor, HER2 human epidermal growth factor 2, MC mitotic count, NS Nottingham score, tHb total hemoglobin, TN triple negative
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us